Dr. Kraynack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Perkins Sq
Akron, OH 44308Phone+1 330-543-8009Fax+1 330-543-8890
Education & Training
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Pediatric Pulmonology, 2000 - 2003
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1997 - 2000
- Georgetown University School of MedicineClass of 1997
- University of PennsylvaniaBA, Biology, Summa Cum Laude, 1993
Certifications & Licensure
- OH State Medical License 1998 - 2026
- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Top Doctors Cleveland Magazine's, 2010
- Best Doctors Akron Magazine's, 2009
- Outstanding Research Award Postgraduate Day, Akron Children's Hospital, 2005
- Join now to see all
Clinical Trials
- Effect of Simvastatin on CF Airway Inflammation Start of enrollment: 2004 Jul 01
- Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis Start of enrollment: 2007 Oct 01
Publications & Presentations
PubMed
- 59 citationsStatin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.Norman E. Kreiselmeier, Nathan C. Kraynack, Deborah A. Corey, Thomas J. Kelley
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2003-08-29 - 44 citationsMechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cellsNathan C. Kraynack, Deborah A. Corey, Heather L. Elmer, Thomas J. Kelley
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2002-09-01 - 59 citationsApproach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers.Nathan C. Kraynack, M. David Gothard, Lynn Falletta, John T. McBride
Pediatric Pulmonology. 2011-09-01
Journal Articles
- Approach to Treating Cystic Fibrosis Exacerbations vary Widely Across US Care CentersKraynack, N., Gothard, MD, Faletta, L., McBride, J., Pediatric Pulmonolgy, 1/1/2011
- Statin-mediated Correction of Stat1 Signaling and NOS2 Expression in Cystic Fibrosis Epithelial CellsKreiselmeier, N., Kraynack, N., Corey, D., and Kelley, T, Am J Physiol, Lung Cell Mol Physiol, 1/1/2003
- The Regulation of NOS2 Expression by Rho GTPases in Airway Epithelial CellsKraynack NC, Corey D, Elmer H, and Kelley TJ, Am J Physiol, Lung Cell Mol Physiol, 1/1/2002
- Join now to see all
Lectures
- Congenital Central Hypoventilation Syndrome: Revenge of the Water Nymph!1/1/2014
- Cystic Fibrosis: Pathophysiology and Treatment1/1/2014
- The Influence of Mucin and Synthetic Cystic Fibrosis Medium on the in Vitro Bioactivity of Silver Carbene Complexes and Select AntimicrobialsWashington D.C. - 1/1/2014
- Join now to see all
Press Mentions
- Cystic Fibrosis: 5 Ways to Help Your Child Live a Longer, Healthier LifeNovember 6th, 2017
- Undiagnosed Diseases Prevalent in the UAEJanuary 25th, 2016
- Cystic Fibrosis Program Gains Accreditation from U.S. Cystic Fibrosis FoundationAugust 22nd, 2017
Professional Memberships
- Fellow
- Member
- Member
- International Society for Heart and Lung TransplantationMember
- International Pediatric Lung Transplant Consortium Steering CommitteeMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: